TNG-462 (Vopimetostat): Mechanism of Action

TNG-462 (Vopimetostat) MOA:Targeting PRMT5/MTAP-MTA Pathway for Pancreatic Ductal Adenocarcinoma

🎯 check TNG-462 (Vopimetostat) product page

TNG-462 (Vopimetostat) is a potent, selective, and MTA-cooperative PRMT5 inhibitor. It affects PRMT5-mediated epigenetic signaling by binding to the PRMT5-MTA complex to block methyltransferase activity, effectively inhibiting tumor cell proliferation in MTAP-deleted cancers.

Primary Applications and Mechanism of Action